aminopterin

DRUG4 trials

Sponsors

Genzyme, a Sanofi Company, Rutgers, The State University of New Jersey, Syntrix Biosystems, Inc.

Conditions

Acute Lymphocytic LeukemiaEndometrial CancerLeukemiaPsoriasis

Phase 1

Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis

CompletedNCT00937027

Syntrix Biosystems, Inc.Psoriasis

Start: 2009-06-30End: 2010-04-30Updated: 2019-09-20

Phase 2

Aminopterin in Treating Patients With Refractory Leukemia

CompletedNCT00003305

Genzyme, a Sanofi CompanyLeukemia

Start: 1997-07-31End: 2007-09-30Target: 75Updated: 2014-01-06

Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer

WithdrawnNCT00003821

Genzyme, a Sanofi CompanyEndometrial Cancer

Start: 1998-01-31Updated: 2018-09-18

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

CompletedNCT00176462

Rutgers, The State University of New JerseyAcute Lymphocytic Leukemia

Start: 2001-02-28End: 2008-09-30Updated: 2014-06-09